Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Keefe, Bruyette & Woods Maintains Outperform on Bank7, Raises Price Target to $40-Report Released on 29 January 2024

Author: Benzinga Newsdesk | January 30, 2024 09:37am
Keefe, Bruyette & Woods analyst Brady Gailey maintains Bank7 (NASDAQ:BSVN) with a Outperform and raises the price target from $38 to $40.

Posted In: BSVN